Hiv capsid protein genetic diversity across hiv-1 variants and impact on new capsid-inhibitor lenacapavir

HIGHLIGHTS

• who: Africa Holguu00edn from the Translacional Infecciones Pediu00e1tricas (RITIP), Madrid, Spain Columbia University Irving Medical have published the research work: HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir, in the Journal: (JOURNAL)
• what: At the same time, the authors report, for the first time to the knowledge , the single natural polymorphisms in p24 that can be considered as genetic markers of each HIV-1 variant or V-markers.
• how: In the analysis sites G89 and P90 were highly conserved in all the studied HIV-1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.